November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer – Kiran Patel
Jul 18, 2023, 05:37

Positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer – Kiran Patel

Today, The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer (NSCLC) characterized by specific genetic alterations.

We’re advancing the science of lung cancer through the development of targeted therapies for patients with genetically-defined NSCLC who often experience poor prognoses and shorter survival.

We remain focused on bringing forward transformative treatment options to reduce the impact of the world’s leading cause of cancer mortality.

Read more about these results: https://bit.ly/3JXLh5l

 

Source: Kiran Patel / LinkedIn